What Happened?
Seattle, WA-based Nohla Therapeutics Appointed Kathleen Fanning as Chief Executive Officer
About the Company
Nohla Therapeutics is a cellular therapy company driven to provide leading off the shelf therapies for patients with critical diseases. Nohla’s first product is a universal donor cell therapy targeting hematopoietic recovery and chemotherapy induced neutropenia, and is being extended to treat a range of other medical indications. This and other products in the pipeline are based on a unique umbilical cord blood expansion platform developed at the Fred Hutchinson Cancer Research Center
About the Person
Kathleen Fanning is Chief Executive Officer at Nohla Therapeutics. Previously, Kathleen held various senior HR leadership roles in the industry.
Info Source
News
Short Profile